Demerol and Postictal state - a phase IV clinical study of FDA data

Summary:

Postictal state is reported as a side effect among people who take Demerol (meperidine hydrochloride), especially for people who are female, 50-59 old, also take Decadron, and have Agranulocytosis.

The phase IV clinical study analyzes which people have Postictal state when taking Demerol. It is created by eHealthMe based on reports of 12,407 people who have side effects when taking Demerol from the FDA, and is updated regularly.

What is Demerol?

Demerol has active ingredients of meperidine hydrochloride. It is often used in pain. eHealthMe is studying from 12,706 Demerol users. Check the latest studies of Demerol.

What is Postictal state?

Postictal state is found to be associated with 181 drugs and 354 conditions by eHealthMe. Check the latest studies of Postictal state.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

12,407 people reported to have side effects when taking Demerol.
Among them, 25 people (0.2%) have Postictal state.

Among these 25 people:

What is the gender of people who have Postictal state when taking Demerol? *

female: 100 %
male: 0.0 %

What is the age of people who have Postictal state when taking Demerol? *

What are other drugs people take besides Demerol? *

What are other side effects people have besides Postictal state? *

Blood Osmolarity Decreased: 21 people, 84.00%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 19 people, 76.00%
Vaginal Bleeding Between Periods: 1 person, 4.00%
Rashes (redness): 1 person, 4.00%
Malaise (a feeling of general discomfort or uneasiness): 1 person, 4.00%
Fever: 1 person, 4.00%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 4.00%
Cholecystitis Chronic (long lasting infection of gallbladder): 1 person, 4.00%
Cholecystitis (infection of gallbladder): 1 person, 4.00%

What are the existing conditions these people have? *

High Blood Pressure: 24 people, 96.00%
Breast Cancer: 24 people, 96.00%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 24 people, 96.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 4.00%
Gait Disturbance: 1 person, 4.00%
Birth Control: 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Demerol and have Postictal state?

- Check whether Postictal state is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Demerol:

Demerol (12,706 reports)

Postictal state treatments and more:

Postictal state (1,223 reports)

Browse all side effects of Demerol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Postictal state:

Postictal state (182 drugs)

Browse all the conditions that are associated with Postictal state:

Postictal state (354 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on meperidine hydrochloride (the active ingredients of Demerol) and Demerol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.